Similarly, HDAC6/10 inhibition increased accumulation of doxorubicin in two other neuroblastoma cell lines, IMR-32 (Fig. 3h) and SK-N-AS (Fig. 3i). This evidence concerns the gene HDAC6 and neuroblastoma.